Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and potential health benefits. While the
Author: admin
Michael Saylor meets SEC’s new crypto task force to discuss U.S. regulations
Microstrategy’s founder Michael Saylor met with the U.S. Securities and Exchange Commission’s (SEC) newly unveiled crypto task force to discuss how digital assets should
Wall Street Analysts Are Bullish on Top Energy Picks
There’s a lot to be optimistic about in the Energy sector as 3 analysts just weighed in on Santos Limited (STOSF – Research Report),
Mortgage Rates Fell Again Friday—to a New 2025 Low. Here’s How Much That Could Save You on Monthly Payments.
Key Takeaways Mortgage rates fell for a second straight week, dropping the flagship average to a new 10-week low. Rates on new 30-year fixed-rate
Buyers Cautious as Rates Decrease
Mortgage rates dropped, but buyer activity stayed low last week. A Fed rate cut seems unlikely, though bond policy changes could eventually lower rates.
Jesse Plemons Doesn’t ‘Regret’ Gaining Weight for Role — But He Probably Won’t Do It Again
Jesse Plemons. Eamonn M. McCormack/Getty Images for The Walt Disney Company Limited Jesse Plemons is opening up about gaining weight for his role in
Sleep apnea: What is a mouth guard and why is it trending?
HOUSTON – “What is a mouth guard” and “Sleep apnea” are trending on Google search as Americans are trying to find ways to get
This mid-cap stock rise 4% despite stock market crash. Do you own it?
Stock Market today: The mid-cap stock Triveni Engineering & Industries Ltd gained 4% in the intraday trades on Monday despite stock market crash. Triveni
“Chokepoints” looks at the rewards and risks of modern U.S. economic warfare
The United States imposes three times as many economic sanctions as any other country in the world, according to an analysis by The Washington
Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months — and It's Not Eli Lilly or Novo Nordisk
Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as the